Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TG Therapeutics Inc Approves For Listing On NASDAQ Capital Market


Tuesday, 28 May 2013 08:30am EDT 

TG Therapeutics Inc announced that its common stock has been approved for listing on the NASDAQ Capital Market (NASDAQ) and is expected to commence trading on NASDAQ under the ticker symbol TGTX on May 30, 2013. The Company's common stock will continue to trade on the Over-the-Counter Bulletin Board until the market close on May 29, 2013. 

Company Quote

16.18
0.15 +0.94%
26 Dec 2014